There are other blood ccancers that LBC can offer further information and support around. Some of these are listed below.
CMML has high numbers of white blood cells, called monocytes, in the bloodstream and bone marrow. CMML has features of both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN).
The Leukaemia Foundation (Australia) has some useful information about CMML. Click here to open.
Plasma cell leukaemia, also called plasma cell myeloma, is when a significant amount of abnormal plasma cells have left the bone marrow and are released into the bloodstream.
Plasma cell leukaemia is considered to be a more advanced form of myeloma and usually requires more intensive treatment and monitoring. There is more information about myeloma in this booklet.
Waldenström’s macroglobulinaemia (WM) is a slow-growing type of non-Hodgkin lymphoma. It is also called lymphoplasmacytic lymphoma.
Waldenstrom’s macroglobulinaemia affects a specific type of white blood cell called the B-lymphocyte. Some B-lymphocytes develop into plasma cells, which produce antibodies when foreign substances such as bacteria or viruses are detected in the body. However, in Waldenstrom’s macroglobulinaemia, B-lymphocytes do not develop into mature plasma cells, but into a type of cancer cell known as a lymphoplasmacytoid cell. These abnormal cells grow more quickly than normal cells would and can invade and build up in the bone marrow, spleen, and lymph glands.
For more useful information about WM follow the below links:
Waldenström’s Macroglobulinemia Study Involving CART-WHEEL
MacMillian Cancer Support (UK)
Leukaemia Foundation Australia
Interntational Waldenstroms Macroglobulinemia Foundation (IWMF)